Susquehanna International Group
DAWN

Susquehanna International Group’s Day One Biopharmaceuticals DAWN Stock Holding History

Susquehanna International Group’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.3M Buy
200,400
+171,600
+596% +$2.42M ﹤0.01% 4519
2025
Q4 		$268K Sell
28,800
-14,000
-33% -$117K ﹤0.01% 10220
2025
Q3 		$302K Buy
+42,800
New +$294K ﹤0.01% 10091
2025
Q2 		– Sell
-10,100
Closed -$80.1K – 12813
2025
Q1 		$80.1K Sell
10,100
-10,300
-50% -$111K ﹤0.01% 11673
2024
Q4 		$258K Buy
20,400
+1,200
+6% +$16.7K ﹤0.01% 10147
2024
Q3 		$267K Sell
19,200
-2,800
-13% -$39.9K ﹤0.01% 9838
2024
Q2 		$303K Buy
+22,000
New +$322K ﹤0.01% 9423
2023
Q3 		– Sell
-16,900
Closed -$202K – 12153
2023
Q2 		$202K Sell
16,900
-3,300
-16% -$43.1K ﹤0.01% 10247
2023
Q1 		$270K Sell
20,200
-44,000
-69% -$859K ﹤0.01% 9952
2022
Q4 		$1.38M Sell
64,200
-7,500
-10% -$154K ﹤0.01% 5469
2022
Q3 		$1.44M Buy
71,700
+17,700
+33% +$376K ﹤0.01% 5705
2022
Q2 		$967K Buy
+54,000
New +$558K ﹤0.01% 6611

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Susquehanna International Group's DAWN Position: Q1 2026 in Review

Susquehanna International Group reduced its Day One Biopharmaceuticals (DAWN) stake by 36% in Q1 2026, selling an estimated $3.72M and leaving 473,543 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3097.

Susquehanna International Group first reported a position in DAWN in Q1 2022 and has held it in 16 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Susquehanna International Group held 473,543 shares of Day One Biopharmaceuticals worth $10.2M as of Q1 2026.
  • Susquehanna International Group sold 264,117 Day One Biopharmaceuticals shares in Q1 2026, an estimated $3.72M.
  • Day One Biopharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3097 holding.
  • Susquehanna International Group first reported a position in Day One Biopharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.